Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature


Kantarcioglu B., Kaygusuz-Atagunduz I., Uzay A., TOPTAŞ T., Tuglular T. F., Bayik M.

INTERNATIONAL JOURNAL OF HEMATOLOGY, cilt.102, sa.3, ss.383-387, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 102 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s12185-015-1792-2
  • Dergi Adı: INTERNATIONAL JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.383-387
  • Anahtar Kelimeler: t(9;22), Myelodysplastic syndrome, BCR-JAK2, Fusion gene, JAK2 rearrangement, CHRONIC EOSINOPHILIC LEUKEMIA, ACUTE LYMPHOBLASTIC-LEUKEMIA, CHRONIC MYELOID-LEUKEMIA, JAK2, TRANSLOCATION, PATIENT, GENE, RUXOLITINIB, REARRANGEMENTS, DISORDERS
  • Marmara Üniversitesi Adresli: Evet

Özet

The human JAK2 gene is mainly targeted by two types of genetic lesions that play roles in the pathogenesis of hematologic malignancies: intragenic mutations and chromosomal translocations. Chromosomal translocations of JAK2 are typically associated with myeloid or lymphoid malignancies with an aggressive course and poor outcome. Here we report a t(9;22)(p24;q11.2) translocation, in a MDS patient and review results associated with BCR-JAK2 fusion reported in the literature.